MyLeukemiaTeam

Are Keytruda and Pegasys 135 similar drugs?

These are actually quite different types of treatments, even though both can play a role in cancer care.

Pegasys (pegylated interferon alfa-2a) is an interferon therapy. It works by slowing the growth of cancer cells and encouraging immune cells, like T cells, to attack them Show Full Answer

Are Keytruda and Pegasys 135 similar drugs?

These are actually quite different types of treatments, even though both can play a role in cancer care.

Pegasys (pegylated interferon alfa-2a) is an interferon therapy. It works by slowing the growth of cancer cells and encouraging immune cells, like T cells, to attack them. The "pegylated" part means it's been chemically modified to stay in the bloodstream longer, allowing for lower doses and potentially fewer side effects.

Keytruda (pembrolizumab) is an immunotherapy drug known as a checkpoint inhibitor. It works differently — it essentially "unmasks" cancer cells so the immune system can recognize and attack them.

Here's a quick comparison:

- Type: Pegasys is an interferon; Keytruda is a checkpoint inhibitor
- How they work: Both involve the immune system, but through very different mechanisms
- Leukemia use: Pegasys is approved for certain leukemia types, including chronic myeloid leukemia (CML) and hairy cell leukemia (HCL)

It's always best to speak with a hematologist or oncologist about which treatment options are appropriate for your specific type and stage of leukemia.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Interferon Therapy for Leukemia: When Is It Used?